Assessment of MBL2 gene polymorphism and lipid peroxidation in Chronic Obstructive Pulmonary Disease (COPD)
© Sharma et al; licensee BioMed Central Ltd. 2014
Published: 21 January 2014
Chronic Obstructive Pulmonary Disease (COPD) is fourth leading cause of death worldover. It has been defined as a state characterized by airflow obstruction due to inflammatory reaction. Various innate and adaptive immune system molecules are involved in pathogenesis of COPD. Mannose-binding lectin (MBL) is a Ca2+ dependent collagenous lectin which intervene immune response by inhibiting pathogen activity. Point mutations, in codon 54 and 57 of exon 1 of the MBL2 have been reported to affect the serum levels of MBL. Aim of the present study was to investigate the association of MBL2 gene polymorphism with severity and susceptibility towards COPD.
129 COPD patients and 90 age- and sex-matched controls were recruited for the study. Genomic DNA was isolated from blood samples. PCR-RFLP of codon 54 and 57 of the MBL2 were studied using enzymes BanI and MboII respectively. In addition to this, serum MDA concentrations were evaluated by TBA-TCA-HCl method. Genotypic distribution was compared by odds ratio statistics using medcal software. Differences in MDA concentrations were analyzed by student’s‘t’ test using SPSS version 18.0 (IL, USA, and Chicago).
The genotypic frequencies of codon 54 in COPD patients were significantly higher (p< 0.05) than that of controls. GG genotype was found to be more prevalent in cases (OR= 3.402; CI= 1.14-10.10; p< 0.05). However, there was no significant difference in genotypic distribution for codon 57 of MBL2 gene. Serum MDA concentrations were significantly (p< 0.001) higher in patients (9.00±2.906) as compare to controls (6.31±2.361).
The results of the present study revealed that MBL2 polymorphism may be involved in pathogenesis of COPD.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.